ARCHIVES

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

This article is from The Cancer Letter archive.

Vol. 26 No. 6 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

Patients “Raise A Voice” For Provenge Approval.

April 27, 2007

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

February 5, 1999

FDA Approves Gleevec For First Line Rx Of CML

January 31, 2003

In Brief: Harold Moses Directs Vanderbilt Cancer Center; Carl Fretts, NIH contracts Director, To Retire

June 11, 1993

South Carolina Politicos Join Hollings Oncology Center Section

October 30, 1992

‘Interactive Research Project Grants’ Proposed, Goal To Provide Step Between R01s and P01s

October 25, 1991